Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 21-Aug-24 6:49 PM View:  | Ars Pharmaceuticals, Inc. (SPRY) | 20-Aug-24 | Option Exercise | 12,500 | $1.50 | $18,750.00 | 95% 13.2K to 25.7K | |
| 21-Aug-24 6:49 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 20-Aug-24 | Planned Option Sale | 12,500 | $16.00 | $200,000.00 | (49%) 25.7K to 13.2K | |
| 01-Dec-22 4:31 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 29-Nov-22 | Purchase | 8,250 | $6.24 | $51,506.40 | 100% 0 to 8.25K | |
| 07-Oct-22 5:05 PM View: | Dermata Therapeutics, Inc. (DRMA) | 06-Oct-22 | Grant | 11,359 | -- | -- | 62% 18.23K to 29.58K | |
| 08-Jul-22 4:10 PM View: | Dermata Therapeutics, Inc. (DRMA) | 07-Jul-22 | Grant | 9,960 | -- | -- | 121% 8.27K to 18.23K | |
| 08-Apr-22 7:17 PM View: | Dermata Therapeutics, Inc. (DRMA) | 07-Apr-22 | Grant | 5,826 | -- | -- | 239% 2.44K to 8.27K |